[Type I glutaric aciduria: an unrecognized cause of progressive dystonia]

N Gouider-Khouja1, I Ben Youssef-Turki

  • 1Service de Neurologie Pédiatrique, Institut National de Neurologie, Tunis, Tunisie. neziha.khouja@rns.tn

Revue Neurologique
|October 10, 2006
PubMed

Insights

Glutaric acidemia type I presents variably, often mimicking other conditions. Early diagnosis through organic acid chromatography is crucial for timely dietary intervention to slow disease progression.

Area of Science:

  • Neurology
  • Metabolic Disorders
  • Pediatrics

Background:

  • Glutaric acidemia type I (GA-I) is an underdiagnosed organic acidemia due to variable and confusing presentations.
  • GA-I can manifest with progressive neurological symptoms, including dystonia, spastic quadriplegia, or choreoathetosis, often mimicking encephalitis in infancy.
  • Cerebral MRI typically reveals enlarged cerebrospinal fluid spaces and basal ganglia abnormalities.

Observation:

  • A case report details an eight-year-old boy with GA-I presenting at 18 months with motor difficulties and limb abnormalities.
  • The patient exhibited generalized dystonia, dysarthria, and tongue dystonia, with normal IQ.
  • Family history revealed deceased siblings with similar symptoms and another sister with severe quadriplegia, highlighting intrafamilial variability.

Findings:

  • MRI confirmed basal ganglia high T2 signal and enlarged CSF spaces.
  • Urinary organic acid chromatography definitively diagnosed Glutaric acidemia type I.
  • The intrafamilial presentation demonstrated significant variability in clinical course and severity.

Implications:

  • This case underscores the importance of considering GA-I in children with acute or progressive dystonia and basal ganglia abnormalities on MRI.
  • Systematic organic acid chromatography is proposed for early diagnosis.
  • Prompt diagnosis allows for appropriate dietary management, potentially slowing disease progression.
Abstract

Related Concept Videos

Alterations in Muscle Tone ll01:12

Alterations in Muscle Tone ll

Alterations in muscle tone are common manifestations of neurological disorders and reflect dysfunction within different nervous system regions. Spasticity, paratonia, and dystonia represent distinct forms of hypertonia, each with unique mechanisms, clinical features, and diagnostic importance.CharacteristicsSpasticity happens from upper motor neuron lesions and is characterized by velocity-dependent resistance to passive movement. Clinical features include:Exaggerated deep tendon reflexesClonus...
Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
Alterations in Muscle Tone lll01:11

Alterations in Muscle Tone lll

Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...